Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Ferrero

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Bulletin Du Cancer|June 13, 2003
[Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast]Jean-Marc Ferrero, Nicolas Magné, Cyril Foa, et al.
Bulletin Du Cancer|November 28, 2008
[Antidepressants in oncology: issues and clinical perspectives]Jérôme Barrière, Faredj Cherikh, Dominique Pringuey, et al.
Anti-Cancer Drugs|August 24, 2006
Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridineJean-Louis Fischel, Joseph Ciccolini, Patricia Formento, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for TreatmentOlivier Guérin, Jean Louis Fischel, Jean-Marc Ferrero, et al.
Bulletin Du Cancer|June 22, 2021
[Targeting the cyclin-dependent kinases 4/6 in advanced breast cancers]Florence Coussy, Elise Deluche, Barbara Pistilli, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patientsCécile Ortholan, Jean-Michel Hannoun-Lévi, Jean-Marc Ferrero, et al.
Breast (Edinburgh, Scotland)|July 9, 2013
Prognostic factors of brain metastases from breast cancer: impact of targeted therapiesAntoine Laurent Braccini, David Azria, Simon Thezenas, et al.
British Journal of Cancer|May 6, 2022
Checkpoint inhibitors in a marriage: consented or arranged?Patrick Brest, Sadal Refae, Baharia Mograbi, et al.
American Journal of Clinical Oncology|April 11, 2002
Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: results of a 10-year experienceNicholas Magné, Eric François, Laure Broisin, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancerJean-Marc Ferrero, Emmanuel Chamorey, Nicolas Magné, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Bulletin Du Cancer|June 13, 2003
[Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast]Jean-Marc Ferrero, Nicolas Magné, Cyril Foa, et al.
Bulletin Du Cancer|November 28, 2008
[Antidepressants in oncology: issues and clinical perspectives]Jérôme Barrière, Faredj Cherikh, Dominique Pringuey, et al.
Anti-Cancer Drugs|August 24, 2006
Synergistic cytotoxic interaction in hormone-refractory prostate cancer with the triple combination docetaxel-erlotinib and 5-fluoro-5'-deoxyuridineJean-Louis Fischel, Joseph Ciccolini, Patricia Formento, et al.
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for TreatmentOlivier Guérin, Jean Louis Fischel, Jean-Marc Ferrero, et al.
Bulletin Du Cancer|June 22, 2021
[Targeting the cyclin-dependent kinases 4/6 in advanced breast cancers]Florence Coussy, Elise Deluche, Barbara Pistilli, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patientsCécile Ortholan, Jean-Michel Hannoun-Lévi, Jean-Marc Ferrero, et al.
Breast (Edinburgh, Scotland)|July 9, 2013
Prognostic factors of brain metastases from breast cancer: impact of targeted therapiesAntoine Laurent Braccini, David Azria, Simon Thezenas, et al.
British Journal of Cancer|May 6, 2022
Checkpoint inhibitors in a marriage: consented or arranged?Patrick Brest, Sadal Refae, Baharia Mograbi, et al.
American Journal of Clinical Oncology|April 11, 2002
Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: results of a 10-year experienceNicholas Magné, Eric François, Laure Broisin, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2002
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancerJean-Marc Ferrero, Emmanuel Chamorey, Nicolas Magné, et al.
Pageof 17